{"name": "Viral Genetics", "permalink": "viral-genetics", "crunchbase_url": "http://www.crunchbase.com/company/viral-genetics", "homepage_url": "http://www.viralgenetics.com", "blog_url": "", "blog_feed_url": "", "twitter_username": "", "category_code": "biotech", "number_of_employees": null, "founded_year": 1995, "founded_month": null, "founded_day": null, "deadpooled_year": null, "deadpooled_month": null, "deadpooled_day": null, "deadpooled_url": null, "tag_list": "", "alias_list": "", "email_address": "", "phone_number": "626-334-5310", "description": "Infections Disease Therapeutics", "created_at": "Thu Sep 10 11:52:35 UTC 2009", "updated_at": "Thu Sep 10 22:59:08 UTC 2009", "overview": "\u003Cp\u003EViral Genetics, Inc. engages in the research and development of protein-based therapeutic and diagnostic products with applications in infectious disease, autoimmune conditions, and immunological deficiency. The company discovers, develops, and commercializes a series of proprietary proteins based primarily on Thymus Nuclear Protein (TNP). TNP is a processed extract of mammalian thymus tissue. The company owns 100% of a Chinese subsidiary called Viral Genetics Beijing, Ltd. VGV-1 VGV-1 is a suspension of TNP in alum adjuvant. It is the company\u00e2\u20ac\u2122s lead drug candidate and is a prospective treatment for HIV infection and AIDS. VGV-1 is in the preclinical stage of development in the USA. History Viral Genetics, Inc. was founded in 1995.\u003C/p\u003E", "image":  {"available_sizes":    [[[150,       33],      "assets/images/resized/0005/9346/59346v1-max-150x150.jpg"],     [[250,       56],      "assets/images/resized/0005/9346/59346v1-max-250x250.jpg"],     [[283,       64],      "assets/images/resized/0005/9346/59346v1-max-450x450.jpg"]],   "attribution": null}, "products":  [], "relationships":  [], "competitions":  [], "providerships":  [], "total_money_raised": "$0", "funding_rounds":  [], "investments":  [], "acquisition": null, "acquisitions":  [{"price_amount": 241000.0,    "price_currency_code": "USD",    "term_code": null,    "source_url": "http://www.fiercebiotech.com/press-releases/viral-genetics-inc-completes-acquisition-v-clip-pharmaceuticals-inc",    "source_description": "Viral Genetics, Inc. Completes Acquisition of V-Clip Pharmaceuticals, Inc.",    "acquired_year": 2008,    "acquired_month": 11,    "acquired_day": 17,    "company":     {"name": "V-Clip Pharmaceuticals",      "permalink": "v-clip-pharmaceuticals"}}], "offices":  [{"description": "",    "address1": "1321 Mountain View Circle",    "address2": "",    "zip_code": "91702",    "city": "Azusa",    "state_code": "CA",    "country_code": "USA",    "latitude": null,    "longitude": null}], "milestones":  [], "ipo": null, "video_embeds":  [], "screenshots":  [], "external_links":  []}